WELLCOME APPOINTS MHP GROUP

The global charitable foundation brings in MHP Group to understand and improve the research field community dynamics in mental health

Wellcome has appointed MHP Group to deliver a programme of research as part of its mental health strategy work.

Working with Wellcome’s mental health team, MHP Health will generate insights into the constructiveness of conversations in mental health research and convene members from across the field to explore and design ways to improve them. Wellcome hopes this can help foster a more cohesive and collaborative mental health research field in the future.

As part of its mental health strategy, Wellcome aims to create transformative change by developing new and better ways for earlier intervention to enable people experiencing mental health challenges to thrive. The emphasis is on funding a diverse range of researchers and driving greater collaboration among stakeholders in the field of mental health.

Alison Dunlop, Senior Director, MHP Health, added:

“We are delighted to partner with Wellcome on such a critical and complex challenge, which will support the mental health research community to address mental health challenges globally. This appointment reflects the strength of our Health Communications capabilities, which combine deep health knowledge with broader strategic and creative expertise.”

MHP Health’s key clients include AstraZeneca, Takeda and Boehringer Ingelheim, with communications campaigns being delivered for a range of clients, including the World Bladder Cancer Patient Coalition, BeiGene, Santen, Myeloma UK and Bupa.